Deep Health AI India accepts resignation of independent director
- Rajesh Nandkishore Pherwani resigns as Independent Director effective September 11, 2026
- Cites personal pre-occupation as the sole reason for departure
- Company notifies BSE under Regulation 30 of SEBI Listing Regulations
- Pherwani retains directorship at Kshitij Polyline Limited

*this image is generated using AI for illustrative purposes only.
Deep Health AI Limited has accepted the resignation of Rajesh Nandkishore Pherwani as Non-Executive Independent Director, effective close of business on September 11, 2026. The departure follows Pherwani’s citation of personal pre-occupation and unavailability to devote sufficient time to company affairs.
The company notified the BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Narayan Singh Rathore, Managing Director, confirmed the acceptance and enclosed the resignation letter.
Resignation Details
Pherwani (DIN: 07576485) tendered his resignation due to personal commitments. He confirmed there were no material reasons for his exit other than those stated. The Board acknowledged receipt and initiated necessary filings with the Ministry of Corporate Affairs.
| Particular | Description |
|---|---|
| Resigning Director | Rajesh Nandkishore Pherwani |
| Designation | Non-Executive Independent Director |
| Effective Date | September 11, 2026 |
| Reason | Personal pre-occupation |
Other Directorships
Pherwani currently serves as a Non-Executive Independent Director at Kshitij Polyline Limited. He holds no committee memberships in other listed entities.
Historical Stock Returns for Deep Health AI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +0.55% | -8.54% | -34.77% | -55.72% | 0.0% |
How will Deep Health AI plan to fill the vacancy left by Rajesh Nandkishore Pherwani to maintain board independence and compliance?
Could the departure of an independent director signal any underlying governance concerns or strategic shifts within Deep Health AI?
What impact might this leadership change have on investor confidence and the company's stock performance in the short term?


































